Fluofarma Overview

  • Founded
  • 2003
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 17
Employees
  • Latest Deal Type
  • M&A

Fluofarma General Information

Description

Provider of content analysis technologies to perform and develop cell-based assays. The company offers following services including assay development, cell-based screening, drug profiling, predictive toxicology, biomarker analysis in blood and tissues.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Monitoring Equipment
Acquirer
Primary Office
  • 2 rue Robert Escarpit
  • 33600 Pessac
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Fluofarma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 10-Dec-2015 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Fluofarma’s complete valuation and funding history, request access »

Fluofarma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fluofarma Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Incubateur Régional d'Aquitaine Accelerator/Incubator 000 0000 000000 0
To view Fluofarma’s complete investors history, request access »